Editorial – HCC in HCV patients and the direct acting antivirals: is there really a link?

A. Marrone; G. Franci; A. Perrella; R. Nevola; A. Chianese; L.E. Adinolfi; F.C. Sasso; L. Rinaldi

首页> 外文期刊>European review for medical and pharmacological sciences. >Editorial – HCC in HCV patients and the direct acting antivirals: is there really a link?

【24h】

Editorial – HCC in HCV patients and the direct acting antivirals: is there really a link?

机译：编辑 - HCC在HCV患者和直接代理抗病毒毒率：真的有一个链接吗？

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The onset of hepatocellular carcinoma (HCC) in hepatitis C virus (HCV) patients who achieved thesustained virological response (SVR) after treatment with direct acting antivirals (DAAs) is still a matterof study and debate.

机译：丙型肝炎病毒（HCV）肝细胞癌（HCC）的发作（HCV）患者在用直接代理抗病毒（DAAS）治疗后实现了病毒性反应（SVR）仍然是一个研究和辩论。

著录项

来源
《European review for medical and pharmacological sciences.》 |2020年第2期|共5页
作者
A. Marrone; G. Franci; A. Perrella; R. Nevola; A. Chianese; L.E. Adinolfi; F.C. Sasso; L. Rinaldi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Editorial: reciprocal interaction between HCV direct‐acting anti‐virals (DAA) and hepatocellular carcinoma (HCC)—a negative impact of HCC on sustained virologic response not of DAA on HCC [J] . Hollande Clémence, Pol Stanislas Alimentary pharmacology & therapeutics. . 2019,第2期

机译：编辑：HCV直接作用抗病毒（DAA）和肝细胞癌（HCC）之间的相互作用 - HCC对HCC对DAA的持续病毒性反应的负面影响
2. Role of abbreviated MRI protocol for screening of HCC in HCV related cirrhotic patients prior to direct-acting antiviral treatment [J] . Ahmed Nora Nabil Abdou, El Gaafary Sahar Mohamed, Elia Remon Zaher, The Egyptian Journal of Radiology and Nuclear Medicine . 2020,第1期

机译：缩写MRI方案在直接作用抗病毒治疗之前HCV相关肝硬化患者HCC筛选的作用
3. Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study [J] . Luca Rinaldi, Alessandro Perrella, Maria Guarino, Journal of Translational Medicine . 2019,第1期

机译：直接代理抗病患者治疗HCV患者早期HCC发生的发病率和危险因素：预期多期面研究
4. Incorporation of a DIRECT ACTING ANTIVIRAL Treatment for HEPATITIS C in the Brazilian Public Health System [C] . Mayra Braga Lemos, Milene Rangel da Costa, Rosimary Terezinha de Almeida Brazilian Congress on Biomedical Engineering . 2019

机译：加入巴西公共卫生系统丙型肝炎直接作用抗病毒治疗
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation [O] . Juliet A. Emamaullee, Mariusz Bral, Glenda Meeberg, 2019

机译：HCV根除与直接作用抗病毒药不会影响肝移植后的候诊肝癌进展或肝癌复发
7. HCV Eradication with Direct-Acting Antivirals Does Not Impact HCC Progression on the Waiting List or HCC Recurrence after Liver Transplantation [O] . Juliet A. Emamaullee, Mariusz Bral, Glenda Meeberg, 2019

机译：用直效抗病毒杀虫的HCV消除不会影响肝移植后等待名单或HCC复发的HCC进展

Editorial – HCC in HCV patients and the direct acting antivirals: is there really a link?

摘要

著录项

相似文献

相关主题

期刊订阅